Gary, I love the nautical reference in your opening

New Post Public Reply Private Reply Replies (4) Message Board
BruceLake GaryM #14584
540
Gary, I love the nautical reference in your opening paragraph. As much as the company has tried over the last few years, all that they have done is hit one iceberg after another. The fact the ship has not yet sunk is both a miracle and a testament to the company's resolve.

I've commented on this in the past and I will repeat it again. A reverse split, if implemented, may very well guarantee the company's survival or, at the very least, prolong it. I can't say this will be the case for the existing shareholders. Some will argue that the company will not necessarily go through with the reverse split, and if they do it may not be to the degree that some are fearing. If this is your view than vote accordingly.

A few other points that you and others have raised and that I would like to address:

1. Management's capacity to get a snapshot of the voting to date: I suppose this may be possible, but generally there is a third party that tallies the votes. As we all know voting fraud is very real and prevalent in all types of elections. SEC laws give companies and their board of directors a lot more leeway than shareholder advocates would like. In this regard the SEC regulators continue to implement measures to protect shareholders. Here are a couple of links that partly address the voting process and issues.

https://qz.com/85929/here-is-how-four-compani...ers-votes/

http://100fstreet.com/index.php/2011/02/the-a...lculation/

2. The possibility of the company implementing a "1 for 2, 3, or even 10" reverse split. It is not going to happen with the current proposal! Let me remind you that when the company contemplated all this, the share price was $.093. So what exactly will a 1 for 3 split do, bring us back to where we were before all of this started? I think I mentioned it before that as long as the R/S "elephant" is in the room. The share price will continue to hover at it's current range. If the current proposal is approved then all bets are off.

3. A few times you've raised the point that the company still has lots of room to raise capital given that they have a total of 500 million authorized shares. Yes this is true. But the real room for raising capital is in the 20 million shares of authorized preferred stock. As you know 500 of these were used to raise the $5 million investment. You are right. How much more room does the company need? Obviously the company wants a lot more! Consider the following: As of the record date there were 156,897,345 common shares outstanding, and 465 Series A preferred stock issued and outstanding. If the company were to implement the maximum 1 for 500 reverse split, the number of common shares remaining would be reduced to 313,794 shares...meaning that with the # of authorized shares still remaining at 500 million the company would still have 99.937% room to issue more shares. And of course the kicker is that these would be at the 500 times higher price! Folk please get your heads out of the sand for the moment and think about the above.

4. Let's obliterate out of the water the myth, idea, or impression that somehow before the vote on April 4, there will be a more definitive proposal put forward to the shareholders. IT CANNOT HAPPEN AND IT WILL NOT HAPPEN...did I put enough emphasis there with my caps? The reason I say this is because they cannot change the proxy material midstream especially when we are two weeks away from the vote. This is not just my opinion, it is against the SEC rules. The company can of course issue a clarification before the vote, or they have the option of extending the deadline. By the way it was just yesterday that I received my proxy material in the mail. Hardly enough time if I opted to go the snail mail route!

5. I just read lodge's last post. I too would love to be proven wrong and believe me I want to be wrong but I am not about to forget everything I have learned over the years.

Good luck to all of us...we'll need it!!!

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 3

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 5

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 4

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 4

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights Into December's Top Mobile and CTV Apps for Revenue

Updated Category News Views 170

Top Revenue Generating Mobile and CTV Apps for December 2024 The evolving landscape of mobile and Connected TV (CTV) applications continually captivates users and advertisers alike. As 2024 comes to a close, the spotlight shines on the highest-grossing apps in North America, specifically in the United States and Canada, revealing significant trends in user engagement and...

Continue Reading
LET Mining's Cloud Strategy for XRP: Earn Passive Income Today

Updated Category News Views 106

Introduction to LET Mining's New Approach LET Mining is making waves with its innovative strategy that leverages XRP for cloud mining. This fresh perspective has caught the attention of numerous XRP holders, sparking excitement about its long-term profit potential. As more users join the platform, LET Mining is focusing on refining its computing power allocation to...

Continue Reading
Understanding Recent Changes in American Intl Gr's Short Interest

Updated Category News Views 70

Understanding American Intl Gr's Short Interest Dynamics American Intl Gr (AIG) has recently seen a notable change in its short percent of float, which has decreased by 3.24% since the last report. This change reflects a current total of 10.23 million shares sold short, making up approximately 1.79% of all available shares for trading. With the current trading volume,...

Continue Reading
Exploring the Future of the Phosphate Market: Growth and Trends

Updated Category News Views 520

The Rising Phosphate Market: An Overview The phosphate market is experiencing remarkable growth, projected to soar to approximately $219.74 billion in the coming years, driven by an annual growth rate of 3.9%. This growth is closely linked to the rising global demand for agricultural fertilizers, which play a crucial role in providing essential nutrients for plants....

Continue Reading
Clene Inc. to Engage with Investors at Benchmark Conference

Updated Category News Views 108

Clene Inc. to Engage with Investors at Benchmark Conference Clene Inc. (Nasdaq: CLNN), a dynamic clinical-stage biopharmaceutical company, is making its mark in the healthcare industry by focusing on innovative solutions for neurodegenerative diseases. Their mission is clear: to enhance mitochondrial health and safeguard neuronal functions. With a commitment to tackling...

Continue Reading